Elite Medical-Surgical Test Bank
Protocol v3.1
PART I: THE PRIMER
Mastering high-acuity medical-surgical nursing transforms the amateur into the apex clinical
leader capable of averting multi-system failure. The 2026/2027 standard demands zero
hesitation, replacing academic memorization with absolute physiological command.
● Sepsis (2026): Initiate peripheral norepinephrine via large-bore antecubital IV
immediately for MAP < 65; do not delay for central access.
● Stroke: Tenecteplase (TNK) 0.25 mg/kg IV push is the standard, supplanting Alteplase
infusions.
● COPD: A single moderate exacerbation mandates escalation to LABA+LAMA or triple
therapy.
● Burns: Resuscitate at 2 mL/kg/%TBSA; titrate strictly to 30-50 mL/hr urine output to
prevent lethal fluid creep.
● MASH: Calculate FIB-4 prior to hepatology referral for all metabolic syndrome patients.
PART II: THE ELITE TEST BANK
Q1: To validate a diagnosis of pediatric sepsis under the 2026 Phoenix Sepsis Criteria,
the clinician must identify a score of ≥2 indicating potentially life-threatening dysfunction
in which specific organ systems? A) Respiratory, Cardiovascular, Coagulation, and
Neurological. B) Renal, Hepatic, Cardiovascular, and Respiratory. C) Integumentary,
Immunological, Hepatic, and Renal. D) Respiratory, Gastrointestinal, Neurological, and
Endocrine.
● The Answer: A (Respiratory, Cardiovascular, Coagulation, and Neurological)
● Distractor Analysis: Options B, C, and D incorrectly apply adult SOFA parameters or
irrelevant physiological systems. The pediatric Phoenix Criteria specifically eliminated
reliance on generalized SIRS criteria and isolated the evaluation to four high-yield
systems.
● The Mentor's Analysis: Children are not little adults; they maintain vascular tone much
longer before experiencing catastrophic collapse. The 2026 Phoenix Sepsis Score (PSS)
is strictly calibrated to specific physiological parameters to detect early decompensation
before irreversible shock occurs.
Organ System Key 2026 Phoenix Parameter
Respiratory PaO2/FiO2 ratio degradation
Cardiovascular Vasoactive drug requirement / severe
hypotension
Coagulation Platelet count drop / D-dimer elevation
Neurological Glasgow Coma Scale (GCS) decline
Q2: A 62-year-old patient with Acute Ischemic Stroke (AIS) presents 2.5 hours after
,symptom onset. There are no contraindications to thrombolysis. Per the 2026 AHA/ASA
Guidelines, what is the optimal reperfusion strategy? A) Alteplase 0.9 mg/kg continuous
infusion over 60 minutes. B) Tenecteplase (TNK) 0.25 mg/kg administered as a single 5-10
second IV bolus. C) Heparin infusion titrated to a PTT of 60-80 seconds. D) Withhold systemic
thrombolytics and await mechanical thrombectomy.
● The Answer: B (Tenecteplase (TNK) 0.25 mg/kg administered as a single 5-10 second IV
bolus)
● Distractor Analysis: Option A is the legacy standard; while acceptable, TNK is preferred
for its workflow advantages and recanalization rates. Option C is contraindicated in AIS.
Option D fatally delays reperfusion; IV thrombolysis must be given even if thrombectomy
is planned.
● The Mentor's Analysis: TNK is the 2026 standard of care. It features higher fibrin
specificity and an extended half-life compared to alteplase, allowing for a single bolus
administration. This drastically reduces "door-to-needle" times, optimizing early
recanalization.
Q3: According to the 2026 GOLD Report on COPD, a patient classified in Group A
experiences a single moderate exacerbation requiring systemic corticosteroids. What is
the mandatory pharmacological adjustment? A) Maintain the current Short-Acting Beta
Agonist (SABA) and schedule a 6-month follow-up. B) Escalate immediately to a LABA+LAMA
combination therapy to achieve a low disease activity state. C) Initiate continuous home oxygen
therapy at 2 L/min. D) Prescribe an inhaled corticosteroid (ICS) as a monotherapy.
● The Answer: B (Escalate immediately to a LABA+LAMA combination therapy)
● Distractor Analysis: Option A ignores the 2026 paradigm shift regarding exacerbation
risks. Option C is premature without hypoxic failure. Option D is contraindicated; ICS is
never used as monotherapy in COPD due to pneumonia risks.
● The Mentor's Analysis: The 2026 GOLD report revolutionized COPD management by
recognizing that even a single moderate exacerbation significantly increases the risk of
subsequent acute events and cardiovascular complications. You escalate to dual
bronchodilation immediately to force disease stability and halt the inflammatory trajectory.
Q4: In the context of ERAS (Enhanced Recovery After Surgery) 2026 protocols, which
preoperative intervention represents a paradigm shift from traditional surgical dogma? A)
Enforcing a strict nil per os (NPO) status from midnight prior to surgery. B) Administering a
carbohydrate-rich beverage two hours prior to anesthesia induction. C) Utilizing heavy
preoperative opioid loading to preempt surgical pain. D) Aggressive mechanical bowel
preparation for all abdominal surgeries.
● The Answer: B (Administering a carbohydrate-rich beverage two hours prior to
anesthesia induction)
● Distractor Analysis: Option A induces starvation kinetics and insulin resistance. Option
C violates multi-modal, opioid-sparing principles. Option D induces dehydration and
electrolyte derangements.
● The Mentor's Analysis: ERAS protocols dismantle legacy practices. Administering a clear
carbohydrate drink two hours prior to surgery switches the body from a catabolic
starvation state to an anabolic state, mitigating the surgical stress response, reducing
post-operative insulin resistance, and accelerating tissue healing.
Q5: According to the American Burn Association 2026 standards, how should a nurse
calculate the initial fluid resuscitation rate for an 80 kg adult with a 40% TBSA deep
partial-thickness burn? A) 4 mL x 80 kg x 40% TBSA, giving all fluid in the first 8 hours. B)
Use the "Rule of 10," estimating 400 mL/hr as the initial starting rate. C) 2 mL x 80 kg x 40%
, TBSA, dividing the total evenly over 24 hours. D) Administer 1000 mL/hr of 0.9% Normal Saline
empirically.
● The Answer: B (Use the "Rule of 10," estimating 400 mL/hr as the initial starting rate)
● Distractor Analysis: Option A is the outdated Parkland timing and risks massive fluid
creep. Option C incorrectly distributes the fluid. Option D guarantees hyperchloremic
acidosis and pulmonary edema.
● The Mentor's Analysis: The "Rule of 10" simplifies initial 24-hour resuscitation to prevent
mathematical errors in high-stress trauma. For adults 40-80 kg, multiply the %TBSA by 10
to get the initial hourly rate (40 x 10 = 400 mL/hr). From there, abandon the formula and
titrate strictly to a urine output of 30-50 mL/hr to prevent lethal over-resuscitation.
Q6: A patient with Chronic Kidney Disease (CKD) Stage 5 on hemodialysis requires
anemia management per the 2026 KDIGO guidelines. The patient's ferritin is 450 ng/mL
and TSAT is 25%. What is the preferred intervention? A) Initiate a Hypoxia-Inducible
Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI). B) Administer blood transfusions to maintain
hemoglobin above 120 g/L. C) Administer proactive intravenous iron therapy. D) Withhold all
treatments until ferritin drops below 100 ng/mL.
● The Answer: C (Administer proactive intravenous iron therapy)
● Distractor Analysis: Option A (HIF-PHIs) remains a secondary consideration due to
cardiovascular safety concerns compared to established ESAs/Iron. Option B is
contraindicated due to alloimmunization risks. Option D forces the patient into severe iron
deficiency.
● The Mentor's Analysis: The 2026 KDIGO guidelines adopt proactive IV iron regimens for
hemodialysis patients, targeting a ferritin ceiling of 700 ng/mL and TSAT of 40% before
withholding. This limits ESA requirements and maximizes erythropoiesis without triggering
iron overload toxicity.
Q7: You are evaluating a patient with Metabolic Dysfunction-Associated Steatohepatitis
(MASH). To accurately risk-stratify for advanced fibrosis before referral to hepatology,
what is the mandatory 2026 first-line non-invasive test (NIT)? A) Percutaneous liver biopsy.
B) Fibrosis-4 (FIB-4) index calculation. C) Magnetic Resonance Elastography (MRE). D)
Alpha-fetoprotein (AFP) serum levels.
● The Answer: B (Fibrosis-4 (FIB-4) index calculation)
● Distractor Analysis: Option A is invasive, costly, and no longer a first-line screening tool.
Option C is a second-line or specialized test. Option D screens for hepatocellular
carcinoma, not fibrosis staging.
● The Mentor's Analysis: Global MASH consensus guidelines in 2026 dictate that primary
care and medical-surgical nurses must utilize the FIB-4 index. It requires only standard
lab values (Age, AST, ALT, Platelets) and instantly stratifies patients. A score <1.3
indicates low risk, whereas ≥1.3 triggers second-line testing (VCTE/FibroScan).
Q8: A patient receiving a monoclonal antibody immune checkpoint inhibitor (ICPi) for
melanoma develops Grade 3 immune-related colitis (severe abdominal pain, >7 stools
above baseline). Per 2026 NCCN Guidelines, what is the immediate protocol? A) Continue
the ICPi and administer loperamide. B) Suspend the ICPi temporarily and administer
broad-spectrum antibiotics. C) Permanently discontinue the ICPi and initiate high-dose systemic
corticosteroids (1-2 mg/kg/day). D) Administer a 500 mL fluid bolus and continue the ICPi
infusion at a 50% reduced rate.
● The Answer: C (Permanently discontinue the ICPi and initiate high-dose systemic
corticosteroids)
● Distractor Analysis: Option A ignores a life-threatening autoimmune crisis. Option B
Protocol v3.1
PART I: THE PRIMER
Mastering high-acuity medical-surgical nursing transforms the amateur into the apex clinical
leader capable of averting multi-system failure. The 2026/2027 standard demands zero
hesitation, replacing academic memorization with absolute physiological command.
● Sepsis (2026): Initiate peripheral norepinephrine via large-bore antecubital IV
immediately for MAP < 65; do not delay for central access.
● Stroke: Tenecteplase (TNK) 0.25 mg/kg IV push is the standard, supplanting Alteplase
infusions.
● COPD: A single moderate exacerbation mandates escalation to LABA+LAMA or triple
therapy.
● Burns: Resuscitate at 2 mL/kg/%TBSA; titrate strictly to 30-50 mL/hr urine output to
prevent lethal fluid creep.
● MASH: Calculate FIB-4 prior to hepatology referral for all metabolic syndrome patients.
PART II: THE ELITE TEST BANK
Q1: To validate a diagnosis of pediatric sepsis under the 2026 Phoenix Sepsis Criteria,
the clinician must identify a score of ≥2 indicating potentially life-threatening dysfunction
in which specific organ systems? A) Respiratory, Cardiovascular, Coagulation, and
Neurological. B) Renal, Hepatic, Cardiovascular, and Respiratory. C) Integumentary,
Immunological, Hepatic, and Renal. D) Respiratory, Gastrointestinal, Neurological, and
Endocrine.
● The Answer: A (Respiratory, Cardiovascular, Coagulation, and Neurological)
● Distractor Analysis: Options B, C, and D incorrectly apply adult SOFA parameters or
irrelevant physiological systems. The pediatric Phoenix Criteria specifically eliminated
reliance on generalized SIRS criteria and isolated the evaluation to four high-yield
systems.
● The Mentor's Analysis: Children are not little adults; they maintain vascular tone much
longer before experiencing catastrophic collapse. The 2026 Phoenix Sepsis Score (PSS)
is strictly calibrated to specific physiological parameters to detect early decompensation
before irreversible shock occurs.
Organ System Key 2026 Phoenix Parameter
Respiratory PaO2/FiO2 ratio degradation
Cardiovascular Vasoactive drug requirement / severe
hypotension
Coagulation Platelet count drop / D-dimer elevation
Neurological Glasgow Coma Scale (GCS) decline
Q2: A 62-year-old patient with Acute Ischemic Stroke (AIS) presents 2.5 hours after
,symptom onset. There are no contraindications to thrombolysis. Per the 2026 AHA/ASA
Guidelines, what is the optimal reperfusion strategy? A) Alteplase 0.9 mg/kg continuous
infusion over 60 minutes. B) Tenecteplase (TNK) 0.25 mg/kg administered as a single 5-10
second IV bolus. C) Heparin infusion titrated to a PTT of 60-80 seconds. D) Withhold systemic
thrombolytics and await mechanical thrombectomy.
● The Answer: B (Tenecteplase (TNK) 0.25 mg/kg administered as a single 5-10 second IV
bolus)
● Distractor Analysis: Option A is the legacy standard; while acceptable, TNK is preferred
for its workflow advantages and recanalization rates. Option C is contraindicated in AIS.
Option D fatally delays reperfusion; IV thrombolysis must be given even if thrombectomy
is planned.
● The Mentor's Analysis: TNK is the 2026 standard of care. It features higher fibrin
specificity and an extended half-life compared to alteplase, allowing for a single bolus
administration. This drastically reduces "door-to-needle" times, optimizing early
recanalization.
Q3: According to the 2026 GOLD Report on COPD, a patient classified in Group A
experiences a single moderate exacerbation requiring systemic corticosteroids. What is
the mandatory pharmacological adjustment? A) Maintain the current Short-Acting Beta
Agonist (SABA) and schedule a 6-month follow-up. B) Escalate immediately to a LABA+LAMA
combination therapy to achieve a low disease activity state. C) Initiate continuous home oxygen
therapy at 2 L/min. D) Prescribe an inhaled corticosteroid (ICS) as a monotherapy.
● The Answer: B (Escalate immediately to a LABA+LAMA combination therapy)
● Distractor Analysis: Option A ignores the 2026 paradigm shift regarding exacerbation
risks. Option C is premature without hypoxic failure. Option D is contraindicated; ICS is
never used as monotherapy in COPD due to pneumonia risks.
● The Mentor's Analysis: The 2026 GOLD report revolutionized COPD management by
recognizing that even a single moderate exacerbation significantly increases the risk of
subsequent acute events and cardiovascular complications. You escalate to dual
bronchodilation immediately to force disease stability and halt the inflammatory trajectory.
Q4: In the context of ERAS (Enhanced Recovery After Surgery) 2026 protocols, which
preoperative intervention represents a paradigm shift from traditional surgical dogma? A)
Enforcing a strict nil per os (NPO) status from midnight prior to surgery. B) Administering a
carbohydrate-rich beverage two hours prior to anesthesia induction. C) Utilizing heavy
preoperative opioid loading to preempt surgical pain. D) Aggressive mechanical bowel
preparation for all abdominal surgeries.
● The Answer: B (Administering a carbohydrate-rich beverage two hours prior to
anesthesia induction)
● Distractor Analysis: Option A induces starvation kinetics and insulin resistance. Option
C violates multi-modal, opioid-sparing principles. Option D induces dehydration and
electrolyte derangements.
● The Mentor's Analysis: ERAS protocols dismantle legacy practices. Administering a clear
carbohydrate drink two hours prior to surgery switches the body from a catabolic
starvation state to an anabolic state, mitigating the surgical stress response, reducing
post-operative insulin resistance, and accelerating tissue healing.
Q5: According to the American Burn Association 2026 standards, how should a nurse
calculate the initial fluid resuscitation rate for an 80 kg adult with a 40% TBSA deep
partial-thickness burn? A) 4 mL x 80 kg x 40% TBSA, giving all fluid in the first 8 hours. B)
Use the "Rule of 10," estimating 400 mL/hr as the initial starting rate. C) 2 mL x 80 kg x 40%
, TBSA, dividing the total evenly over 24 hours. D) Administer 1000 mL/hr of 0.9% Normal Saline
empirically.
● The Answer: B (Use the "Rule of 10," estimating 400 mL/hr as the initial starting rate)
● Distractor Analysis: Option A is the outdated Parkland timing and risks massive fluid
creep. Option C incorrectly distributes the fluid. Option D guarantees hyperchloremic
acidosis and pulmonary edema.
● The Mentor's Analysis: The "Rule of 10" simplifies initial 24-hour resuscitation to prevent
mathematical errors in high-stress trauma. For adults 40-80 kg, multiply the %TBSA by 10
to get the initial hourly rate (40 x 10 = 400 mL/hr). From there, abandon the formula and
titrate strictly to a urine output of 30-50 mL/hr to prevent lethal over-resuscitation.
Q6: A patient with Chronic Kidney Disease (CKD) Stage 5 on hemodialysis requires
anemia management per the 2026 KDIGO guidelines. The patient's ferritin is 450 ng/mL
and TSAT is 25%. What is the preferred intervention? A) Initiate a Hypoxia-Inducible
Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI). B) Administer blood transfusions to maintain
hemoglobin above 120 g/L. C) Administer proactive intravenous iron therapy. D) Withhold all
treatments until ferritin drops below 100 ng/mL.
● The Answer: C (Administer proactive intravenous iron therapy)
● Distractor Analysis: Option A (HIF-PHIs) remains a secondary consideration due to
cardiovascular safety concerns compared to established ESAs/Iron. Option B is
contraindicated due to alloimmunization risks. Option D forces the patient into severe iron
deficiency.
● The Mentor's Analysis: The 2026 KDIGO guidelines adopt proactive IV iron regimens for
hemodialysis patients, targeting a ferritin ceiling of 700 ng/mL and TSAT of 40% before
withholding. This limits ESA requirements and maximizes erythropoiesis without triggering
iron overload toxicity.
Q7: You are evaluating a patient with Metabolic Dysfunction-Associated Steatohepatitis
(MASH). To accurately risk-stratify for advanced fibrosis before referral to hepatology,
what is the mandatory 2026 first-line non-invasive test (NIT)? A) Percutaneous liver biopsy.
B) Fibrosis-4 (FIB-4) index calculation. C) Magnetic Resonance Elastography (MRE). D)
Alpha-fetoprotein (AFP) serum levels.
● The Answer: B (Fibrosis-4 (FIB-4) index calculation)
● Distractor Analysis: Option A is invasive, costly, and no longer a first-line screening tool.
Option C is a second-line or specialized test. Option D screens for hepatocellular
carcinoma, not fibrosis staging.
● The Mentor's Analysis: Global MASH consensus guidelines in 2026 dictate that primary
care and medical-surgical nurses must utilize the FIB-4 index. It requires only standard
lab values (Age, AST, ALT, Platelets) and instantly stratifies patients. A score <1.3
indicates low risk, whereas ≥1.3 triggers second-line testing (VCTE/FibroScan).
Q8: A patient receiving a monoclonal antibody immune checkpoint inhibitor (ICPi) for
melanoma develops Grade 3 immune-related colitis (severe abdominal pain, >7 stools
above baseline). Per 2026 NCCN Guidelines, what is the immediate protocol? A) Continue
the ICPi and administer loperamide. B) Suspend the ICPi temporarily and administer
broad-spectrum antibiotics. C) Permanently discontinue the ICPi and initiate high-dose systemic
corticosteroids (1-2 mg/kg/day). D) Administer a 500 mL fluid bolus and continue the ICPi
infusion at a 50% reduced rate.
● The Answer: C (Permanently discontinue the ICPi and initiate high-dose systemic
corticosteroids)
● Distractor Analysis: Option A ignores a life-threatening autoimmune crisis. Option B
